معرفی
Debra Auguste is a Professor of Chemical Engineering at Northeastern University, affiliated with the College of Engineering. She leads the Auguste Lab for Responsive Drug Delivery and Tissue Engineering, focusing on bioresponsive drug delivery systems and tissue engineering. Her research integrates principles from chemistry, biology, physics, and medicine to develop targeted therapies for diseases like breast cancer. She joined Northeastern in 2016 and holds a PhD from Princeton University (2005) and an SB from MIT (1999).
Her research interests include designing stimuli-responsive materials, understanding tumor microenvironment interactions, and engineering scaffolds for tissue regeneration. Key projects involve ICAM-1-targeted liposomes for triple-negative breast cancer and pH-sensitive hydrogels for controlled drug release.
Auguste has received prestigious awards such as the Presidential Early Career Award for Scientists and Engineers (PECASE, 2012) and the NIH Director’s New Innovator Award (2012). She actively mentors students and has advised numerous PhD and Master’s researchers. Her lab collaborates with industry and academic partners to advance translational research in nanomedicine and regenerative engineering.
Auguste also promotes diversity in STEM through initiatives like the Science Club for Girls, fostering engagement of middle-school students in science. Her work bridges fundamental engineering principles with clinical applications, aiming to improve therapeutic outcomes and tissue repair strategies.
